Variant report
Variant | nsv596896 |
---|---|
Chromosome Location | chr5:1924628-1926026 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:1922868..1925557-chr5:1925659..1927215,2 | MCF-7 | breast: | |
2 | chr5:1923560..1925350-chr5:1937042..1939475,2 | MCF-7 | breast: | |
3 | chr5:1920038..1922611-chr5:1924901..1927373,2 | MCF-7 | breast: | |
4 | chr5:1923598..1926065-chr5:2006441..2007973,2 | K562 | blood: | |
5 | chr5:1922868..1925557-chr5:1925659..1927215,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568353367 | chr5:1924828-1924829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs140621942 | chr5:1924970-1924971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs552546023 | chr5:1925011-1925012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs10036227 | chr5:1925013-1925014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs571133667 | chr5:1925041-1925042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537043190 | chr5:1925044-1925045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540735595 | chr5:1925193-1925194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs113032132 | chr5:1925201-1925202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs111316690 | chr5:1925202-1925203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs4478361 | chr5:1925303-1925304 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs575058483 | chr5:1925322-1925323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539179061 | chr5:1925329-1925330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs557408340 | chr5:1925331-1925332 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs552996515 | chr5:1925346-1925347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs192383075 | chr5:1925355-1925356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs574571042 | chr5:1925379-1925380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs568023067 | chr5:1925383-1925384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs574278287 | chr5:1925391-1925392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544551599 | chr5:1925402-1925403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs563092691 | chr5:1925431-1925432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs532047544 | chr5:1925492-1925493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs184877195 | chr5:1925505-1925506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551950064 | chr5:1925508-1925509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs560559087 | chr5:1925519-1925520 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs6890530 | chr5:1925537-1925538 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs189253607 | chr5:1925544-1925545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs192063712 | chr5:1925562-1925563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs147470088 | chr5:1925564-1925565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs550583898 | chr5:1925585-1925586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568737550 | chr5:1925596-1925597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs539247224 | chr5:1925647-1925648 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
32 | rs557446381 | chr5:1925666-1925667 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
33 | rs557473682 | chr5:1925748-1925749 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
34 | rs373457703 | chr5:1925757-1925758 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
35 | rs572615752 | chr5:1925784-1925785 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
36 | rs529429588 | chr5:1925797-1925798 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
37 | rs533608897 | chr5:1925799-1925800 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
38 | rs555363091 | chr5:1925801-1925802 | Enhancers Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
39 | rs573523337 | chr5:1925807-1925808 | Enhancers Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
40 | rs139302717 | chr5:1925808-1925809 | Enhancers Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563154729 | chr5:1925920-1925921 | Enhancers Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
42 | rs576130490 | chr5:1925959-1925960 | Enhancers Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
43 | rs578234706 | chr5:1925961-1925962 | Enhancers Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
44 | rs372791775 | chr5:1925981-1925982 | Enhancers Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
45 | rs377343103 | chr5:1925999-1926000 | Enhancers Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
46 | rs11749860 | chr5:1926026-1926027 | Enhancers Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Biliary cancer | 19435499 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16608533 | CNVD |
Cervical cancer | 16585170 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Lung cancer | 17925434 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Breast cancer | 19181860 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Developmental delay | 19490664 | CNVD |
Human papillomavirus | 17975027 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Gastric cancer | 16891809 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Emphysema | 19352772 | CNVD |
Chordoma | 18071362 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Lung cancer | 21911935 | CNVD |
Cri-du chat syndrome | 21549014 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164919 | CNVD |
Oral cancer | 22144094 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Schizophrenia | 23813976 | CNVD |
Ependymoma | 20639864 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:1924200-1928000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr5:1924400-1925600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr5:1925600-1926400 | ZNF genes & repeats | Right Atrium | heart |
4 | chr5:1925600-1927600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr5:1925800-1926400 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
6 | chr5:1926000-1926200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |